Clinical study of reteplase foracute deep venous thrombosis of lower extremity
10.3969/j.issn.1005-6483.2015.06.028
- VernacularTitle:瑞替普酶治疗急性下肢深静脉血栓临床研究
- Author:
Zhijiang LI
;
Xuwen GUAN
;
Shouguo HU
- Publication Type:Journal Article
- Keywords:
reteplase;
rapid intravenous dripping;
continuously venous-pump;
acute deep venous thrombosis of lower extremity
- From:
Journal of Clinical Surgery
2015;(6):472-473,474
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical efficacy and safety of reteplase(rPA)adminis-tration in treating acute deep venous thrombosis(ADVT)of lower extremity.Methods A total of 1 87 pa-tients with ADVT were randomly divided into two groups,with 85 patients in rapid intravenous dripping group and 1 02 patients in 24-hour venouspumping group.Their effects on limb swelling,thrombolysis,and complicationswere compared for analysis.Results The differences in the curative effectsof reducingswell-ingand thrombolysis effect between the two groups werenot significant(P >0.05).Thethrombolysis time in the 24-hour venouspumping group was shorter than that of the rapid intravenous dripping group [(4.76 ± 1 .56)days vs(6.56 ±0.83)days,P <0.05],indicating 24-hour venouspumping was more effective than rapid intravenous dripping.Complication incidence in the 24-hour venouspumping group was less than that of the rapid intravenous dripping group(3.90% vs 1 7.6%,P <0.05).Conclusion rPA is a goodvenous thrombolytic agentwith rapid effect in treating ADVT.The 24-hour venouspumping was more effective and safe than the rapid intravenous dripping.
